公开(公告)号：US20230321101A1

公开(公告)日：2023-10-12

申请号：US18022254

申请日：2021-08-20

申请人： Philip L.S.M. GORDTS ,  Andrea DENARDO ,  Ryan Joseph WEISS ,  Chelsea NORA ,  Jeffrey D. Esko ,  CLAUSEN Thomas Mandel ,  Daniel R. SANDOVAL ,  The Regents of the University of California

发明人： Philip L.S.M. Gordts ,  Andrea Denardo ,  Ryan Joseph Weiss ,  Chelsea Nora ,  Jeffrey D. Esko ,  Thomas Mandel-Clausen ,  Daniel R. Sandoval

IPC分类号： A61K31/517 ,  A61P31/14

CPC分类号： A61K31/517 ,  A61P31/14

摘要： The present disclosure relates to treatment or prevention of a disease, such as COVID-19, in a subject by administering to the subject a therapeutically effective amount of halofuginone or a derivative or pharmaceutically acceptable salt thereof.